REVIEW PAPER
Revisiting copper and zinc in end-stage renal disease patients
1
Department of Chemistry, Faculty of Science, University of Kufa, Iraq
2
Department of Chemistry, Faculty of Science, University of Anbar, Iraq
3
College of Science, Kufa University, Najaf, Iraq
Submission date: 2023-12-22
Final revision date: 2024-02-13
Acceptance date: 2024-02-21
Publication date: 2024-06-27
Corresponding author
Maha Abd Al-Sahab
Dr. Maha Abd Al-Sahab, College of Science, Kufa University, Najaf, Iraq
Dr. Maha Abd Al-Sahab, College of Science, Kufa University, Najaf, Iraq
Pediatr Pol 2024;99(2):143-148
KEYWORDS
TOPICS
ABSTRACT
Numerous research projects have discovered how trace elements affect people with end-stage renal disease (ESRD). Thus, understanding the mechanism of action and the potential treatment options requires research into the chemical compounds that have an impact on the kidneys. Trace elements are components of metalloproteins and act as cofactors for numerous essential enzymes. Among the most important trace elements that affect renal function are zinc and copper. The newly published papers on changes in the effects of both trace element products in ESRD patients were studied, and the justifications gathered from earlier studies were compiled. This review’s findings suggest that changes in trace element levels worsen ESRD patients’ health condition by deepening kidney dysfunction, which has a negative impact on their health. The mechanism by which these effects occur is reviewed, and schemes were plotted in order to show a comprehensive view of the role of dysregulation of copper and zinc in ESRD patients.
REFERENCES (66)
1.
Twaij BAAR, Al-Hakeim HK, Altufaili MF. Review on the neuron damage parameters in patients with end-stage renal disease. J Popul Ther Clin Pharmacol 2023; 30: 408-420.
2.
Chertow GM, Vart P, Jongs N, et al. Effects of dapagliflozin in stage 4 chronic kidney disease. J Am Soc Nephrol 2021; 32: 2352.
3.
Roberts PR, Green D. Arrhythmias in chronic kidney disease. Heart 2011; 97: 766-773.
4.
Moss AH. Ethical considerations in the care of dialysis patients: the new paradigm. Handbook of dialysis therapy, Elsevier 2023, 606-612.
5.
Romagnani P, Remuzzi G, Glassock R, et al. Chronic kidney disease. Nat Rev Dis Prim 2017; 3: 1-24.
6.
Jakimowicz T, Przywara S, Turek J, et al. Five year outcomes in patients with end stage renal disease who received a bioengineered human acellular vessel for dialysis access. EJVES Vasc Forum 2022; 54: 58-63.
7.
Fukushima T, Horike H, Fujiki S, Kitada S, Sasaki T, Kashihara N. Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients. Ther Apher Dial 2009; 13: 213-219.
8.
Guo CH, Wang CL, Chen PC, Yang TC. Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysis. Perit Dial Inter 2011; 31: 583-591.
9.
Montesa MP, Rico MG, Salguero MS, et al. Study of oxidative stress in advanced kidney disease. Nefrologia 2009; 29: 464-473.
10.
Noleto Magalhães RC, Guedes Borges de Araujo C, Batista de Sousa Lima V, Machado Moita Neto J, do Nascimento Nogueira N, do Nascimento Marreiro D. Nutritional status of zinc and activity superoxide dismutase in chronic renal patients undergoing hemodialysis. Nutr Hosp 2011; 26: 1456-1461.
11.
Wakino S. Trace elements and their management in dialysis patients – pathophysiology and clinical manifestations. Kidney Dial 2023; 3: 274-296.
12.
Prodanchuk M, Makarov O, Pisarev E, Sheiman B, Kulyzkiy M. Disturbances of trace element metabolism in ESRD patients receiving hemodialysis and hemodiafiltration. Cent European J Urol 2014; 66: 472-476.
13.
Almeida A, Gajewska K, Duro M, Costa F, Pinto E. Trace element imbalances in patients undergoing chronic hemodialysis therapy – report of an observational study in a cohort of Portuguese patients. J Trace Elem Med Biol 2020; 62: 126580.
14.
Law JP, Pickup L, Pavlovic D, Townend JN, Ferro CJ. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations. J Hum Hypertens 2023; 37: 1-19.
15.
Ali W, Mao K, Zhang H, et al. Comprehensive review of the basic chemical behaviours, sources, processes, and endpoints of trace element contamination in paddy soil-rice systems in rice-growing countries. J Hazard Mater 2020; 397: 122720.
16.
Mahapatra SR, Nimmy P (ed.). Groundwater contamination with heavy metals in Chennai city, India – a threat to the human population. IOP Conference Series: Earth and Environmental Science 2021, IOP Publishing.
17.
Twaij BAAR, Mashkour MS, Al-Hakeim HK. Study and determination of aryl hydrocarbon receptor with some trace elements in fuel filling station workers. J Petrol Res Stud 2020; 10: 233-251.
18.
Zhu X, Zhang Y, Han J, Xiao D, Zhu D, Ou Y. Effects of chronic kidney disease on levels of oxidative stress and trace elements. System Rev Pharma 2022; 13: 128-134.
19.
Islam MR, Akash S, Jony MH, et al. Exploring the potential function of trace elements in human health: a therapeutic perspective. Mol Cell Biochem 2023; 478: 2141-2171.
20.
Chasapis CT, Ntoupa PSA, Spiliopoulou CA, Stefanidou ME. Recent aspects of the effects of zinc on human health. Arch Toxicol 2020; 94: 1443-1460.
21.
Neto L, Bacci M, Sverzutt L, Costa M, Alves B, Fonseca F. The role of zinc in chronic kidney disease patients on hemodialysis: a systematic review. Health 2016; 8: 344.
22.
Esfahani ST, Hamidian MR, Madani A, et al. Serum zinc and copper levels in children with chronic renal failure. Pediatr Nephrol 2006; 21: 1153-1156.
24.
Akar-Ghibril N. Defects of the innate immune system and related immune deficiencies. Clin Rev Allergy Immunol 2022; 63: 36-54.
25.
Humudat YR, Al-Naseri SK. Heavy metals in dialysis fluid and blood samples from hemodialysis patients in dialysis centers in Baghdad, Iraq. J Health Pollut 2020; 10: 200901.
26.
Mafra D, Cuppari L, Cozzolino SM. Iron and zinc status of patients with chronic renal failure who are not on dialysis. J Ren Nutr 2002; 12: 38-41.
27.
Ott ES, Shay NF. Zinc deficiency reduces leptin gene expression and leptin secretion in rat adipocytes. Exp Biol Med (Maywood) 2001; 226: 841-846.
28.
Aranha LN, Lobo JC, Stockler-Pinto MB, de Oliveira Leal V, Torres JPM, Mafra D. Relationship between zinc levels and plasma leptin in hemodialysis patients. J Trace Elem Med Biol 2012; 26: 238-242.
29.
Bozalioğlu S, Özkan Y, Turan M, Şimşek B. Prevalence of zinc deficiency and immune response in short-term hemodialysis. J Trace Elem Med Biol 2005; 18: 243-249.
30.
Davenport A. Prevalence and determinants of low plasma zinc levels in adult peritoneal dialysis patients. J Trace Elem Med Biol 2023; 78: 127171.
31.
Rodic S, McCudden C, van Walraven C. Relationship between plasma zinc and red blood cell zinc levels in hospitalized patients. J Appl Lab Med 2022; 7: 1412-1423.
32.
Palmer BF. Evaluation and treatment of sexual dysfunction. Handbook of Dialysis Therapy, Elsevier 2023, 507-512.
33.
Sam R, Haghighat L, Kjellstrand CM, Ing TS. Hemolysis during hemodialysis. Handbook of Dialysis Therapy, Elsevier 2008, 457.
34.
Kiziltas H, Ekin S, Erkoc R. Trace element status of chronic renal patients undergoing hemodialysis. Biol Trace Elem Res 2008; 124: 103-109.
35.
Hasanato RM. Assessment of trace elements in sera of patients undergoing renal dialysis. Saudi Med J 2014; 35: 365-370.
36.
Dashti-Khavidaki S, Khalili H, Vahedi SM, Lessan-Pezeshki M. Serum zinc concentrations in patients on maintenance hemodialysis and its relationship with anemia, parathyroid hormone concentrations and pruritus severity. Saudi J Kidney Dis Transpl 2010; 21: 641-645.
37.
Abdulla M. How adequate is plasma zinc as an indicator of zinc status? Prog Clin Biol Res 1983; 129: 171-183.
38.
Kambe T, Tsuji T, Hashimoto A, Itsumura N. The physiological, biochemical, and molecular roles of zinc transporters in zinc homeostasis and metabolism. Physiol Rev 2015; 95: 749-784.
39.
Takagi K, Masuda K, Yamazaki M, et al. Metal ion and vitamin adsorption profiles of phosphate binder ion-exchange resins. Clin Nephrol 2010; 73: 30-35.
40.
Damianaki K, Lourenco JM, Braconnier P, et al. Renal handling of zinc in chronic kidney disease patients and the role of circulating zinc levels in renal function decline. Nephrol Dial Transplant 2020; 35: 1163-1170.
41.
Nishime K, Kondo M, Saito K, Miyawaki H, Nakagawa T. Zinc burden evokes copper deficiency in the hypoalbuminemic hemodialysis patients. Nutrients 2020; 12: 577.
42.
Lu J, Stewart AJ, Sadler PJ, Pinheiro TJ, Blindauer CA. Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem Soc Trans 2008; 36: 1317-1321.
43.
Duncan A, Yacoubian C, Watson N, Morrison I. The risk of copper deficiency in patients prescribed zinc supplements. J Clin Pathol 2015; 68: 723-725.
44.
Clarkson A, Paine S, Martín-Tereso J, Kendall N. Copper physiology in ruminants: trafficking of systemic copper, adaptations to variation in nutritional supply and thiomolybdate challenge. Nutr Res Rev 2020; 33: 43-49.
45.
Al-Fartusie FS, Mohssan SN. Essential trace elements and their vital roles in human body. Indian J Adv Chem Sci 2017; 5: 127-136.
46.
Angelova M, Asenova S, Nedkova V, Koleva-Kolarova. Copper in the human organism. Trakia J Sci 2011; 9: 88-98.
47.
Ali SS, Ahsan H, Zia MK, Siddiqui T, Khan FH. Understanding oxidants and antioxidants: classical team with new players. J Food Biochem 2020; 44: e13145.
48.
Chin-Chan M, Montes S, Blanco-Álvarez VM, Aguirre-Alarcón HA, Hernandez-Rodriguez I, Bautista E. Relevance of biometals during neuronal differentiation and myelination: in vitro and in vivo studies. BioMetals 2022; 35: 395-427.
49.
Washington-Hughes CL, Roy S, Seneviratne HK, et al. Atp7b- dependent choroid plexus dysfunction Causes transient copper deficit and metabolic changes in the developing mouse brain. PLoS Gen 2023; 19: e1010558.
50.
Abolaji AO, Fasae KD, Iwezor CE, Aschner M, Farombi EO. Curcumin attenuates copper-induced oxidative stress and neurotoxicity in Drosophila melanogaster. Toxicol Rep 2020; 7: 261-268.
51.
Ay A, Alkanli N, Ustundag S. Investigation of the relationship between IL-18 (- 607 C/A), IL-18 (- 137 G/C), and MMP-2 (- 1306 C/T) gene variations and serum copper and zinc levels in patients diagnosed with chronic renal failure. Biol Trace Elem Res 2022; 200: 2040-2052.
52.
Niu Y, Zhang Y, Zhu Z, et al. Elevated intracellular copper contributes a unique role to kidney fibrosis by lysyl oxidase mediated matrix crosslinking. Cell Death Dis 2020; 11: 211.
53.
Cheng F, Peng G, Lu Y, et al. Relationship between copper and immunity: the potential role of copper in tumor immunity. Front Oncol 2022; 12: 1019153.
54.
Anees M, Mumtaz A, Frooqi S, Ibrahim M, Hameed F. Serum trace elements (aluminium, copper, zinc) in hemodialysis patients. Biomedica 2011; 27: 106-110.
55.
Liu Y, Tang R, Xu Q, et al. High blood Cu/Zn ratio is associated with nutritional risk in patients undergoing maintenance hemodialysis. Biol Trace Elem Res 2022; 200: 4977-4987.
56.
Nakamura H, Ueda M, Anayama M, Makino Y, Nagasawa M. Short-term effects of roxadustat on serum copper and iron changes in a peritoneal dialysis patient. CEN Case Rep 2023; 12: 292-296.
57.
Stojsavljević A, Ristić-Medić D, Krstić D, et al. Circulatory imbalance of essential and toxic trace elements in pre-dialysis and hemodialysis patients. Biol Trace Elem Res 2021; 200: 3117-3312.
58.
Cedeño Y, Miranda M, Orjales I, et al. Serum concentrations of essential trace and toxic elements in healthy and disease-affected dogs. Animals 2020; 10: 1052.
59.
Neuberger J. Liver tests. In: Hirschfieldm GM, Gill P, Neuberger J (eds.). The Liver in systemic disease: a clinician’s guide to abnormal liver tests. John Wiley & Sons Ltd., NY 2023, 1-18.
60.
Stojsavljević A, Ristić-Medić D, Krstić D, et al. Circulatory imbalance of essential and toxic trace elements in pre-dialysis and hemodialysis patients. Biol Trace Elem Res 2022; 200: 3117-3125.
61.
Zischka H, Borchard S. Mitochondrial copper toxicity with a focus on Wilson disease. In: Kerkar N, Roberts EA. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier 2019, 65-75.
62.
Sheline CT, Choi DW. Cu2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo. Ann Neurol 2004; 55: 645-653.
63.
Huang HM, Ou HC, Xu H, Chen HL, Fowler C, Gibson GE. Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death. J Neurosci Res 2003; 74: 309-317.
64.
Eljazzar S, Abu-Hijleh H, Alkhatib D, et al. The role of copper intake in the development and management of type 2 diabetes: a systematic review. Nutrients 2023; 15: 1655.
65.
Nazari-Taloki Z, Salehifar E, Makhlough A, Dashti-Khavidaki S. Effect of recommended dietary intake versus higher doses of supplemental zinc on iron and copper deficiency anemia among patients with chronic kidney diseases, a double-blinded, randomized clinical trial. Pharm Sci 2023; 29: 495-503.
66.
Liu T, Liu Y, Zhang F, Gao Y. Copper homeostasis dysregulation promoting cell damage and the association with liver diseases. Chin Med J 2023; 136: 1653-1662.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
